# Serina Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/serina-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 21 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-25T04:47:06.129701+00:00 |
| Last reviewed | 2026-10-25T04:47:06.129701+00:00 |

## Identity

- Legal name: Serina Therapeutics, Inc.
- Display name: Serina Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-25T04:47:06.129701+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.852 |
| Directors | 12 |
| Committees | 0 |
| Governance events | 16 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Balkrishan Gill: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:5
- Gregory H. Bailey: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:6
- Gregory S. Curhan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:7
- J. Milton Harris: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:8
- Jay Venkatesan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:9
- Karen J. Wilson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:10
- Randall Moreadith, M.D., Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:11
- Remy Gross: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:12
- Srini Tenjarla, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:13
- Stephen Brannan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:14
- Steve Ledger: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:15
- Steven Mintz: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:16

## Executive leadership

- Gregory S. Curhan: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:17
- Randall Moreadith, M.D., Ph.D.: Chief Development Officer. Status: current. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:18
- Srini Tenjarla, Ph.D.: Chief Technical Operations Officer. Status: current. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:19
- Steve Ledger: Chief Executive Officer and Class II Director [CEO]. Status: current. claim_id=alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:20

## Governance events

- DIRECTOR_APPOINTED: Balkrishan Gill seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:13fvzee9hf396
- DIRECTOR_APPOINTED: Gregory H. Bailey seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:15am3u71djwe65
- DIRECTOR_APPOINTED: Gregory S. Curhan seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:rl865gujmyaw
- DIRECTOR_APPOINTED: J. Milton Harris seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:1r2dx9ps1d1u3
- DIRECTOR_APPOINTED: Jay Venkatesan seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:1xrvuau1usbkd2
- DIRECTOR_APPOINTED: Karen J. Wilson seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:9b6s2y155iqie
- DIRECTOR_APPOINTED: Randall Moreadith, M.D., Ph.D. seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:1fwu90x1xxuyor
- DIRECTOR_APPOINTED: Remy Gross seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:3r2t7kc6167g
- DIRECTOR_APPOINTED: Srini Tenjarla, Ph.D. seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:1jw8gkv19omyw9
- DIRECTOR_APPOINTED: Stephen Brannan seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:1ls9d96s46cqy
- DIRECTOR_APPOINTED: Steve Ledger seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:17wefx11qcvgdz
- DIRECTOR_APPOINTED: Steven Mintz seat on Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:16fqdmovyp5y0
- CFO_CHANGED: Gregory S. Curhan executive of Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:13bqpd5yfymrt
- EXECUTIVE_APPOINTED: Randall Moreadith, M.D., Ph.D. executive of Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:1b98i82cj3i2q
- EXECUTIVE_APPOINTED: Srini Tenjarla, Ph.D. executive of Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:7eefsgjlopjq
- CEO_CHANGED: Steve Ledger executive of Serina Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-25T04:47:06.129701+00:00. event_id=alpha:event:transition:1iimpss1sdp58g

## Scoped resources

- `alpha://company/serina-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record
- `alpha://company/serina-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=identity
- `alpha://company/serina-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/serina-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=board
- `alpha://company/serina-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=committees
- `alpha://company/serina-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=leadership
- `alpha://company/serina-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=ownership
- `alpha://company/serina-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=financials
- `alpha://company/serina-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/serina-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=compensation
- `alpha://company/serina-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=governance
- `alpha://company/serina-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/serina-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=audit
- `alpha://company/serina-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=legal
- `alpha://company/serina-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=risk
- `alpha://company/serina-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=cyber
- `alpha://company/serina-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/serina-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=agents
- `alpha://company/serina-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/serina-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=events
- `alpha://company/serina-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=relationships
- `alpha://company/serina-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=assessments
- `alpha://company/serina-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Balkrishan Gill: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:5. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Gregory H. Bailey: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:6. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Gregory S. Curhan: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:7. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- J. Milton Harris: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:8. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Jay Venkatesan: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:9. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Karen J. Wilson: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:10. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Randall Moreadith, M.D., Ph.D.: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:11. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Remy Gross: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:12. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Srini Tenjarla, Ph.D.: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:13. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Stephen Brannan: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:14. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Steve Ledger: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:15. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Steven Mintz: Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:16. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d.
- Gregory S. Curhan: Chief Financial Officer. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:17. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fde7f21b62504880dd703d98e5a9f90f323015f4ebc712d2b4f4609c0ecee732.
- Randall Moreadith, M.D., Ph.D.: Chief Development Officer. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:18. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:882dd8effbffedde78f2ea01907de6bec0da7b06f09b38fd0d280ee3cd839ff0.
- Srini Tenjarla, Ph.D.: Chief Technical Operations Officer. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:19. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3825bc4cf6070775b51e6d95ada7163cb2b3b982857b5d1d8057c4f56245f8e0.
- Steve Ledger: Chief Executive Officer and Class II Director. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:20. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4e9bc58ab5e5c44cb48d11017d54914d04d93e7d5c72efdcd857caecaed313db.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Serina Therapeutics, Inc.. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c32a8917f0606593b56a16e19306def8cd477f556ed468f1c8969d9427189b11.

## Entity Status

- Public listing published. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c32a8917f0606593b56a16e19306def8cd477f556ed468f1c8969d9427189b11.

## Published Fact

- US. Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c32a8917f0606593b56a16e19306def8cd477f556ed468f1c8969d9427189b11.

## Security Listing

- SER (NYSE). Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:security_listing:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c32a8917f0606593b56a16e19306def8cd477f556ed468f1c8969d9427189b11.
- SER (NYSE AMERICAN). Claim: alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c32a8917f0606593b56a16e19306def8cd477f556ed468f1c8969d9427189b11.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:c32a8917f0606593b56a16e19306def8cd477f556ed468f1c8969d9427189b11: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/serina-therapeutics-inc).
- alpha:projection-evidence:document:eceaf2adc5aef28c314dfa18b9b98c4d67b86444437a471f08754e831cf22a4d: [DEF 14A ser-20260427.htm](https://www.sec.gov/Archives/edgar/data/1708599/000170859926000029/ser-20260427.htm).
- alpha:projection-evidence:document:fde7f21b62504880dd703d98e5a9f90f323015f4ebc712d2b4f4609c0ecee732: [SER DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1708599/000170859926000029/ser-20260427.htm).
- alpha:projection-evidence:document:882dd8effbffedde78f2ea01907de6bec0da7b06f09b38fd0d280ee3cd839ff0: [SER DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1708599/000170859926000029/ser-20260427.htm).
- alpha:projection-evidence:document:3825bc4cf6070775b51e6d95ada7163cb2b3b982857b5d1d8057c4f56245f8e0: [SER DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1708599/000170859926000029/ser-20260427.htm).
- alpha:projection-evidence:document:4e9bc58ab5e5c44cb48d11017d54914d04d93e7d5c72efdcd857caecaed313db: [SER DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1708599/000170859926000029/ser-20260427.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/serina-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/serina-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/serina-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/serina-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-10-25T17:21:52.396554+00:00; recorded 2026-10-25T17:21:52.396554+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.